✦ LIBER ✦

Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn's disease

✍ Scribed by A. KASRAN; L. BOON; C. H. WORTEL; R. A. van HOGEZAND; S. SCHREIBER; E. GOLDIN; M. DE BOER; K. GEBOES; P. RUTGEERTS; J. L. CEUPPENS

Book ID: 108604137
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 340 KB
Volume: 22
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2005.02526.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and efficacy of adalimu

Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease

✍ Watanabe, Mamoru; Hibi, Toshifumi; Mostafa, Nael M.; Chao, Jingdong; Arora, Vipi 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 945 KB

Long-term safety and tolerability of don

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease

✍ Pierre Tariot, Steven Salloway, Jane Yardley, Joan Mackell, Margaret Moline 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 197 KB

T1132 Pharmacokinetics and Exposure-Resp

T1132 Pharmacokinetics and Exposure-Response Relationship of Ustekinumab, a Human Monoclonal Antibody to Interleukin 12/23, in Patients with Moderate-to-Severe Crohn's Disease

✍ Fasanmade, Adedigbo A.; Adedokun, Omoniyi J.; Johanns, Jewel R.; Zhou, Honghui; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Tolerability of switching from donepezil

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving

Efficacy and safety of AZD1981, a CRTH2

Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD

✍ Snell, Noel; Foster, Martyn; Vestbo, Jørgen 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 1022 KB

Efficacy, safety, and tolerability of fu

Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in treatment of patients with moderate-to-severe osteoarthritis pain

✍ P. Sanga; N. Katz; E. Polverejan; S. Wang; K. Kelly; C. Oh; J. Thipphawong 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB